Planning for the What Ifs – Mental Health Concerns in Advanced Parkinson’s Disease

Planning for the What Ifs, Part Two

Mental Health Concerns in Advanced Parkinson’s Disease

Today we continue Parkinson’s Disease: Planning for the What Ifs, a special series of posts to address both motor and non-motor issues of people with advanced Parkinson’s disease (PD). We are defining advanced PD as those who are no longer independent in their activities of daily living, and require help for their self-care such as eating, bathing, dressing and toileting. Remember, PD is a very variable condition and many never reach the advanced stages. Additional background and the full introduction to the series is still available if you missed it.

I receive a lot of questions through our Ask a Doctor feature on our website concerning advanced PD, specifically around mental health issues. In a previous blog, I discussed the management of psychosis and behavioral problems in advanced PD. Today I will discuss cognitive decline/dementia, depression, anxiety and apathy in advanced Parkinson’s disease (PD).

General principles when facing mental health issues in Parkinson’s

We will briefly review the general principles to consider when facing cognitive decline, depression, anxiety or apathy in someone with advanced PD,

  • Consider other illnesses or conditions – The first thing to remember when dealing with mental health issues in PD, especially if they seem to arise suddenly, is that they can be triggered or exacerbated by the presence of another illness or condition. A very common scenario is that cognition worsened suddenly as the presenting sign of a urinary tract infection. Learn about other modifiable contributors to cognitive decline in PD. Besides inter-current infection, these conditions include abnormal thyroid function, low vitamin B12, and head trauma.
  • Review medications with the doctor – Certain medications given for urinary frequency, migraine, seizures, anxiety, and other conditions, can interfere with cognitive function. Be sure to review all medications frequently with the neurologist.
  • Consider whether the mental health issue is an OFF phenomenon – depression and anxiety can fluctuate with brain dopamine levels. If this is the case, adjusting PD medications to reduce OFF time can be an effective strategy.
  • Nondrug approaches to managing mental health issues in people with advanced PD should be tried first, tailored to the particular mental health issue that is problematic. This will be discussed below.
  • Treat what can be treated – Consider medications to treat the symptoms that can be treated. For some of these mental health problems, there are medications that can be prescribed to help, although there is variability in how well people respond

Cognitive decline and dementia

Cognitive decline refers to a decrease in thinking abilities including attention, visuo-spatial skills, memory, planning, judgement, and language. Dementia is defined as cognitive decline that affects a person’s ability to carry out their daily activities. Read an excellent overview of cognitive decline in Parkinson’s.

Cognitive profile

Whereas Alzheimer’s disease is characterized by memory loss, with other cognitive domains or areas affected at later stages, PD dementia typically has a different profile. Executive dysfunction or the ability to plan and organize activities in order to solve problems and complete tasks with multiple steps, is often one of the first difficulties to be noticed. Visuo-spatial dysfunction in which a person has trouble navigating the world around him/her is often seen as well. Other cognitive domains can be affected as the dementia progresses.

While people with all types of dementia often report that they feel marginalized and ignored by their peers, this is a particular issue in advanced PD. PD often causes lack of facial expression, soft voice, speech that is difficult to understand and decreased spontaneous body movement. These features can be interpreted by those trying to engage with the person with PD as a lack of interest or an inability to interact socially, when in reality these physical limitations do not necessarily reflect what the person is thinking and feeling. Those viewing the person with advanced PD may assume that the dementia is worse than it is. Attempting to converse with a person with advanced PD can be a struggle and only the most persistent will keep trying.

On the flipside, apathy, or an actual lack of interest or motivation in activities, is common in advanced PD which causes people with advanced PD to disengage from social interactions. Regardless of the attempts of others to connect with the person with advanced PD, motor difficulties, speech difficulties and cognitive difficulties all conspire to make the person with PD retreat from these interactions.

Is it Parkinson’s disease dementia or Dementia with Lewy bodies?

When dementia becomes significant, people with Parkinson’s disease and their caregivers may wonder whether the disease is actually Dementia with Lewy Bodies. Technically, the difference between Parkinson’s disease dementia (PDD) and Dementia with Lewy Bodies (DLB) lies in how quickly the cognitive difficulties develop in relation to the movement issues. In DLB, the cognitive difficulties develop much sooner in the disease course than in PDD, sometimes even prior to the movement difficulties. Because of the similarities between PDD and DLB, current thinking in the medical community is that they should be viewed as related diseases which fall along a continuum of Lewy body disorders. Read a full discussion of Lewy body disorders.

Non-drug approaches

When dementia becomes significant, it can be particularly hard on care partners. Here are some tips to help navigate the cognitive difficulties:

  • Simplify activities into small steps and maintain a regular routine.
  • Keep clutter to a minimum, leaving household items in the same place every day.
  • Try to keep the person with advanced PD engaged mentally. Find activities that the person enjoys. This will vary greatly depending on the extent of the cognitive decline. For most, listening to music and looking through photobooks will likely be possibilities.
  • Try to keep the person with advanced PD engaged socially. This may require your participation in a three-way conversation to interpret what your loved one is saying and encourage as much interaction as possible.
  • Try to keep the person with advanced PD engaged physically. This will also vary greatly depending on the extent of motor disabilities, but encourage as much movement as possible. There are many exercises and movements that can benefit people with PD.
  • When in discussion about something that the person with advanced PD is not understanding don’t give lengthy explanations. Keep it simple.
  • Try not to take it personally. Always remember that the disease is at fault, not your loved one.
  • Join a care partner support group to both get and share ideas with others.

Medication approaches

Rivastigmine is the only FDA-approved medication for Parkinson’s disease dementia, although cognitive benefits in clinical research studies are modest. Other medications in its class are often also used off-label including donepezil and galantamine. Memantine is a medication approved for dementia of Alzheimer’s disease, but it requires further study in PD dementia.

Depression

Depression is a mood disorder that causes persistent feelings of sadness. It can be a very early symptom of Parkinson’s, sometimes appearing before motor symptoms, and can also be prominent in more advanced stages as well. Read here for a summary of depression and PD. Although depression in PD can be reactive, that is, occurring in response to the chronic disease state, a more prominent cause is the chemical imbalances of the disease itself.

Depression in advanced PD can be difficult to diagnose because symptoms can overlap with cognitive decline, apathy, fatigue, agitation, poor sleep, poor appetite, weight loss and social isolation, all of which can be prominent in advanced PD without depression. Also cognitive impairment can make it difficult for people with advanced PD to articulate their thoughts and feelings, making it difficult to know whether depression underlies a symptom.

Non-drug approaches

  • If cognitively able, try psychological counseling.
  • If depression tends to fluctuate with dosing of PD meds, talk with the neurologist about adjusting medications.
  • Try to keep the person with advanced PD engaged mentally, socially and physically. Make a list of activities that the person enjoys and schedule these things more frequently Celebrate successes whenever possible.
  • Find ways that the person can contribute and be sure to recognize his or her contributions.

 

Medication approaches

Depression is one of the mental health challenges of advanced PD that is amenable to treatment with medication. Because of this, when it is not clear if depression is playing a role in a symptom such as poor appetite, or poor sleep, a medication for depression may be tried to see if it offers benefit.

Selective serotonin reuptake inhibitors (SSRIs: e.g., Zoloft®, Paxil®, Celexa® and others) are the anti-depressants prescribed most often in people with PD and depression. These medications are typically well-tolerated and can also treat anxiety, which often accompanies depression in PD. It is important to note, that these medications as a rule need to build up in the body and might not take effect for 4-6 weeks. There are other medications for depression available with other mechanisms of action. If depression in PD does not respond to an SSRI, a referral to a geriatric psychiatrist may be helpful to select an alternative therapy.

Anxiety

Anxiety is the intense, excessive, and persistent worry and fear about everyday situations. Anxiety can be a non-motor symptom in PD at all stages of disease. Read how anxiety and stress are related to PD.

In advanced PD, anxiety can become very prominent and can be increased by hallucinations and delusions. Anxiety can look the same and share many of the features of agitation, discussed as one of the behavioral problems of advanced PD here. For someone with cognitive decline who can’t explain why he or she is upset, it may be hard to tease out an element of anxiety from generally agitated behavior.

Non-drug approaches

  • If cognitively able, try psychological counseling.
  • If anxiety tends to fluctuate with dosing of PD meds, talk with the neurologist about adjusting medications.
  • Keep novelty to a minimum, with simple daily routines.
  • Find ways to distract the person when anxiety is building. Change the topic. Suggest an activity such as a walk.

 

Medication approaches

SSRIs can be used for anxiety and PD. Other medications are available for anxiety, although some can also lead to sedation, increased imbalance and increased confusion, so they need to be used with caution. If hallucinations or delusions are contributing to the anxiety, treating these can be helpful as well. Please see this article for a discussion of treatment of hallucinations and delusions.

Apathy

Apathy is defined as a feeling of indifference or a general lack of interest or motivation in activities. It is a common symptom in PD throughout its course as well as in advanced PD. For a full discussion of apathy, please see this article.

Caregivers often struggle with whether they should insist that the person with PD participate in activities, or whether they should be allowed to be content in their apathy. There is no one right answer to how much encouragement to provide. Typically, if an apathetic person is encouraged to do an activity, they will enjoy it even if they would not have pursued it on their own. Establishing a few non-negotiable activities on the weekly calendar can therefore be helpful.

 

Tips and Takeaways

  • Remember that for many, PD does not reach an advanced stage where mental health issues become problematic.
  • Bring any mental health issues to the attention of the health care team right away so you can discuss ways to mitigate the issues.
  • If these problems arise, first consider whether it is being caused by a medication side effect or another medical illness.
  • If not, consider non-drug approaches first.
  • Mental health issues can be very challenging and upsetting to the care partner. Consider joining a care partner support group – contact APDA (800-223-2732) for help in locating one near you.

Do you have a question or issue that you would like Dr. Gilbert to explore? Suggest a Topic

Dr. Rebecca Gilbert

APDA Vice President and Chief Scientific Officer

Dr. Gilbert received her MD degree at Weill Medical College of Cornell University in New York and her PhD in Cell Biology and Genetics at the Weill Graduate School of Medical Sciences. She then pursued Neurology Residency training as well as Movement Disorders Fellowship training at Columbia Presbyterian Medical Center. Prior to coming to APDA, she was an Associate Professor of Neurology at NYU Langone Medical Center. In this role, she saw movement disorder patients, initiated and directed the NYU Movement Disorders Fellowship, participated in clinical trials and other research initiatives for PD and lectured widely on the disease.

A Closer Look ArticlePosted in Advanced Parkinson’s, Parkinson's Disease Symptoms

DISCLAIMER: Any medical information disseminated via this blog is solely for the purpose of providing information to the audience, and is not intended as medical advice. Our healthcare professionals cannot recommend treatment or make diagnoses, but can respond to general questions. We encourage you to direct any specific questions to your personal healthcare providers.